Nahid Farzam

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

J H Passwell, Shai Ashkenazi, Yonit Banet-Levi et al. · Vaccine · 2010 · 165 citations · Full text

Medicine, 1–4-Year-old Israeli Children, Age-related Efficacy +1

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children

J H Passwell, Shai Ashkenazi, Efrat Harlev et al. · The Pediatric Infectious Disease Journal · 2003 · 94 citations

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity

Irit Ben Aharon, Hadas Bar Joseph, Moran Tzabari et al. · PLoS ONE · 2013 · 36 citations · Full text

S-allylmercapto-N-acetylcysteine up-regulates cellular glutathione and protects vascular endothelial cells from oxidative stress

Nira Izigov, Nahid Farzam, Naphtali Savion · Free Radical Biology and Medicine · 2011 · 34 citations

Inflammation, Reductive Stress, Biochemistry +9

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data

Dani Cohen, Shai Ashkenazi, Rachel Schneerson et al. · Clinical Microbiology and Infection · 2022 · 32 citations · Full text